L-kynurenine induces NK cell loss in gastric cancer microenvironment via promoting ferroptosis

• Published in: Journal of experimental & clinical cancer research Vol. 42; no. 1; pp. 52 - 15
• Main Authors: Cui, Jian-Xin, Xu, Xian-Hui, He, Tao, Liu, Jia-Jia, Xie, Tian-Yu, Tian, Wen, Liu, Jun-Yan
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 01.03.2023; BioMed Central; BMC
• Subjects: Analysis; Animals; Antibodies; Cancer; Cell death; Cytotoxicity; Disease Models, Animal; Ferroptosis; Gastric cancer; Humans; Immunotherapy; Killer cells; Killer Cells, Natural; Kynurenine; L-kynurenine; Mice; NK cell; Prognosis; Stomach cancer; Stomach Neoplasms - genetics; Tumor Microenvironment; Tumors; Ferroptosis; L-kynurenine; Tumor microenvironment; Gastric cancer; NK cell
• ISSN: 1756-9966; 0392-9078; 1756-9966
• DOI: 10.1186/s13046-023-02629-w

Natural killer (NK) cells play a major role in body's fighting against various types of cancers. Their infiltration in the tumor microenvironment (TME) of gastric cancer (GC) are significantly decreased, which has been reported as a robust prognostic marker. However, the causes leading to NK cells loss in GC TME remains poorly understood. We constructed a non-contact co-culturing system and humanized xenograft tumor mice model to detect the influence of GC microenvironment on NK-92 or primary human NK cells viability by flow cytometry. Then through using the specific inhibitors for different types of cell death and examining the surrogate markers, we confirmed ferroptosis in NK cells. Inspired by the accidental discoveries, we constructed a NK-92 cell strain with high expression of GPX4 and treated the humanized xenograft tumor mice model with the NK-92 cells. We found L-KYN, mainly generated through indoleamine 2, 3-dioxygenase (IDO) from GC cells, impaired NK cells viability in TME. Further analysis revealed L-KYN induced ferroptosis in NK cells via an AHR-independent way. Moreover, we found NK cells with higher GPX4 expression showed resistance to L-KYN induced ferroptosis. Based on this, we generated GPX4 over-expressed NK-92 cells, and found these cells showed therapeutic potential towards GC. Our study revealed a novel mechanism to explain the decline of NK cell number in GC TME. Notably, we also developed a potential immunotherapy strategy, which might be beneficial in clinical treatment in the future.